WallStreetZenWallStreetZen

How to Buy Phathom Pharmaceuticals Stock

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases.

Phathom Pharmaceuticals stock last closed at $9.18, up 0.88% from the previous day, and has decreased 10.09% in one year. It has overperformed other stocks in the Biotechnology industry by 0.12 percentage points. Phathom Pharmaceuticals stock is currently +51.36% from its 52-week low of $6.07, and -46.06% from its 52-week high of $17.02.

At the moment, there are 58.48M shares of PHAT outstanding. The market capitalization of PHAT is $536.82M. In the last 24 hours, 370,886 PHAT shares were traded.

How to Buy Phathom Pharmaceuticals Stock

Wondering how to invest in Phathom Pharmaceuticals stock? Here's how.
  1. Figure out where to buy Phathom Pharmaceuticals stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you decide where to buy Phathom Pharmaceuticals stock.
  2. Sign up for your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Deposit money your investment account: Select your payment method and add your details.
  4. Analyze Phathom Pharmaceuticals stock: The Phathom Pharmaceuticals ticker symbol is PHAT. Is Phathom Pharmaceuticals stock a good investment? Should you buy shares of PHAT? How do PHAT's underlying business fundamentals look? Do top analysts think Phathom Pharmaceuticals is a good buy? Why has PHAT's stock price moved recently? (Hint: Our stock market research website can help you decide if PHAT is a good stock to buy).
  5. Make your PHAT buy order: Decide if you will purchase PHAT shares at the current market price or use a limit order to purchase PHAT shares at a specific price.
  6. Keep an eye on your PHAT investment: Create a watchlist to important updates regarding your new investment in Phathom Pharmaceuticals stock.

Step 1: Figure out where to buy Phathom Pharmaceuticals stock

You need a brokerage account in order to access the NASDAQ market and buy PHAT stock.

A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

In our opinion, eToro is the best stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global markets: From Technology to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the globe's top stock exchanges.
  • Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by signing up for an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've chosen your brokerage, the next step is to fill out some personal details so you can invest in PHAT stock today.

How to Open a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal info to start a new trading account.
  1. Submit your information by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your investment account

Now that you've finished signing up on one of the most highly reviewed stock trading apps, you can securely and quickly fund your account:

Check out this video walkthrough to see the process of depositing funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Phathom Pharmaceuticals stock

Once you have chosen the best place to buy Phathom Pharmaceuticals stock, it's important to analyze their stock prior to buying, so you truly wrap your head around the risk as well as the opportunity.

Phathom Pharmaceuticals Metrics

PHAT Price
$9.18
1w %
2.34%
1y %
-10.09%
5y %
N/A
P/E
-2.34x
P/B
-7.38x
P/S
706.15x
PEG
N/A
Revenue
$682.00k
Earnings
-$201.59M
Fore. Rev. Growth
651.65%
Fore. Earn. Growth
N/A
Market Cap
$536.82M
Next Earnings
May 23, 2024
Next Dividend
N/A

Phathom Pharmaceuticals Overview

WallStreetZen was built to help part-time investors perform more accurate fundamental analysis quickly.

You can view all of the due diligence checks on PHAT's stock page.

What is the fair value of PHAT stock?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge PHAT's true value.

You can do additional valuation research on PHAT's stock here.

PHAT Financial Health Overview

Positive Health Checks:

  • PHAT has cash burn of 139214000. It has sufficient cash and short-term investments to cover this for at least one year.
  • PHAT has $384.26M in cash and short term investments. This is sufficient to cover its annual cash burn of $139.21M.
  • There are more short-term assets than short-term liabilities on the PHAT balance sheet.

Negative Health Checks:

  • PHAT debt to equity ratio of -6.69 is negative.
  • PHAT profit margin has gone down from N/A to -29,558.9% in the past year.
  • Total PHAT debt is still negative.
  • There are more long-term liabilities than short-term assets on the PHAT balance sheet.

Is it a good time to buy PHAT stock, according to Wall Street analysts?

Out of 3 sell side analysts who give ratings on PHAT, the consensus analyst rating on PHAT is a Buy

Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.

You can dive deeper into what analysts are forecasting on the Phathom Pharmaceuticals stock forecast page.

PHAT Trading Indicators

SMA10
9.38
SMA20
10.07
SMA50
9.77
SMA100
8.84
SMA200
10.14
MACD
-0.19
MACD Signal
0
MACD Histogram
-0.2
RSI
43.31
Stochastic %K
10.36
Stochastic %D
8.53
StochRSI %K
7.3
StochRSI %D
5.51

Who is buying/selling PHAT?

In the last year, insiders at PHAT have sold more shares than they have bought.

Molly Henderson, CFO and CBO of PHAT, was the latest PHAT insider to sell. They sold $38,128.50 worth of PHAT stock on Apr 8, 2024.

Get more info about who owns PHAT stock here.

Can I get consistent income from PHAT stock?

No, Phathom Pharmaceuticals doesn't provide an income stream by paying out dividends.

What others are saying about PHAT

One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Make your PHAT buy order

There are two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly fine.
  • Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a particular price limit, place a limit order.

Click the Open Trade button and eToro will execute the order.

If you require additional assistance investing in stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Keep an eye on your PHAT investment

Now that you own some PHAT stock, you'll want to keep up with your company.

Start a watchlist to see the latest developments about your PHAT stock.

PHAT Feed

How to Buy Stock in Phathom Pharmaceuticals

To reiterate, here are the 6 steps to buy stock in Phathom Pharmaceuticals:

  1. Figure out where to buy Phathom Pharmaceuticals stock
  2. Sign up for your brokerage account
  3. Deposit money your investment account
  4. Analyze Phathom Pharmaceuticals stock
  5. Make your PHAT buy order
  6. Keep an eye on your PHAT investment

If you need a brokerage, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep track of your investment in Phathom Pharmaceuticals, click below.

NASDAQ: PHAT
$9.18+0.08 (+0.88%)
Updated Apr 26, 2024
Open eToro Account
NASDAQ: PHAT
$9.18+0.08 (+0.88%)
Updated Apr 26, 2024
Open eToro Account

FAQ

How much does it cost to buy one Phathom Pharmaceuticals share?

As of Apr 26, 2024, it costs $9.18 to buy one share of Phathom Pharmaceuticals stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $4, you can buy 0.436 shares of PHAT.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Phathom Pharmaceuticals stock?

According to 3 Wall Street analysts who monitor Phathom Pharmaceuticals, their consensus recommendation is to buy Phathom Pharmaceuticals stock.

What is the best way to buy Phathom Pharmaceuticals stock?

One way to place an order for Phathom Pharmaceuticals stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.